The Rising Influence of Rising Affluence

[12yearplan]

For sure Dew - risk management. OTC and start ups success record terrible.
Just following the conversation here on CAT electrification and not really pumping - I do look for possible new and disruptive things.. we'll see as they say.
[have a starter and watching closely for the proverbial home run contracts ;]
You got me curious and fwiw;
They applied to the NASDAQ end of 2021. Latest thing I could find was ceo interview Aug 2022 I included a little of below 
https://www.exro.com/search?query=nasdaq
.. from a Nasdaq perspective there's been a lot of questions and clarifications on where we are positioned right now for Nasdaq. As we have mentioned in our reporting, we do have our acceptance from Nasdaq. The timing of when we go to Nasdaq will be partly market driven. For right now, today, I don't have that date for you. I'm focused on getting that production across the finish line, on getting us to that revenue. We've hit our first revenue if you've looked at our financials. Yes, it's not big but it's our first revenue and a large portion of it is coming from right here in Detroit from the EVS team. We're starting to see our customer projects progress just the way we all wanted. Our supply chain issues seem to be under control. They're not over. Everybody's still having them. There's a reason why companies are delaying, but we seem to be under control there, nothing that's worrying me. We remain first to market and ahead by a long shot from anybody trying to do the same thing as us. So, from a Nasdaq perspective, I think we're prepped and ready and soon as we know our date, we'll tell you. And then from a litigation perspective still not much more to update you on.

Great board, thanks!..
[.. also, quite attached to my 98' CAT 426c .. kinda like bagholder marriage$ ;]